Filter Results:
(148)
Show Results For
- All HBS Web
(407)
- People (1)
- News (116)
- Research (148)
- Events (10)
- Multimedia (2)
- Faculty Publications (109)
Show Results For
- All HBS Web
(407)
- People (1)
- News (116)
- Research (148)
- Events (10)
- Multimedia (2)
- Faculty Publications (109)
Sort by
- 30 Mar 2018
- What Do You Think?
What Should Mark Zuckerberg Do?
researcher and consultant” identified as Cambridge Analytica used a quiz app on the platform to access personal information of approximately 300,000 Facebook users and, by extension, 49.7 million of their “friends.” The consultant... View Details
- June 2020
- Teaching Note
Fossil Fuel Divestment
By: Michael W. Toffel and Sarah Gulick
Teaching note to accompany HBS case 620-093, Fossil Fuel Divestment, by Michael W. Toffel and Sarah Gulick. View Details
- 2013
- Working Paper
J. Richard Hackman (1940-2013)
By: Ruth Wageman and Teresa M. Amabile
When J. Richard Hackman died in Cambridge, Massachusetts, on January 8, 2013, psychology lost a giant. Six and a half feet tall, with an outsize personality to match, Richard was the leading scholar in two distinct areas: work design and team effectiveness. In both... View Details
Keywords: Social Psychology; Organizational Design; Groups and Teams; Personal Development and Career; Education Industry; Cambridge
Wageman, Ruth, and Teresa M. Amabile. "J. Richard Hackman (1940-2013)." Harvard Business School Working Paper, No. 14-009, July 2013.
- September 2008
- Case
Pfizer Inc: Building an Innovation Center
By: Stefan H. Thomke and Ashok Nimgade
The case describes Pfizer's efforts to build and run an innovation center in Cambridge, Massachusetts. As the center goes through different periods of leadership and strategic models, its relationship with the corporation and other research sites is explored. The case... View Details
Keywords: Innovation and Management; Innovation Strategy; Leadership; Organizational Culture; Research and Development; Pharmaceutical Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Pfizer Inc: Building an Innovation Center." Harvard Business School Case 609-037, September 2008.
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- 27 Jul 2019
- Op-Ed
Does Facebook's Business Model Threaten Our Elections?
co-worker; with 150, it can do better than a family member; and with 300, better than a spouse. But then came the Cambridge Analytica fiasco, when that firm got 250,000 Facebook users to voluntarily give them access to their personal data... View Details
Keywords: by George Riedel
- August 1996
- Teaching Note
Montague Corporation (A) and (B) TN
By: Norman A. Berg and Judith Maas
Teaching Note for (9-395-037) and (9-395-143). View Details
- 09 Sep 2014
- First Look
First Look: September 9
Publications September 2014 Cambridge University Press Consumer Lending in France and America: Credit and Welfare By: Trumbull, Gunnar Abstract—Why did America embrace consumer credit over the course of the twentieth century, when most... View Details
Keywords: Sean Silverthorne
- 28 Aug 2007
- First Look
First Look: August 28, 2007
Herrera, Alastair Iain Johnston, and Rose McDermott, eds. Publication: Cambridge: Cambridge University Press, forthcoming No abstract available. The Rules of Globalization: Case Book Author: Rawi Abdelal, ed. Publication: Singapore: World... View Details
Keywords: Martha Lagace
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
medicine is that most therapeutics were directed at symptoms, not causes.—Eric S. Lander With that in mind, about 200 HBS alumni working in the healthcare field converged in mid-November at the Charles Hotel in Cambridge to learn from... View Details
- July 2014
- Case
Venture Capital at the Harvard Management Company in Historical Perspective
By: Felda Hardymon, Tom Nicholas and Vasiliki Fouka
The compromise between capital preservation and growth has always been central to the performance of the Harvard endowment. Setting an institutional structure for effectively governing this compromise became especially important when the Harvard Management Company... View Details
Keywords: Venture Capital; Financial Management; Asset Management; Higher Education; Investment; Financial Services Industry; Education Industry; Cambridge
Hardymon, Felda, Tom Nicholas, and Vasiliki Fouka. "Venture Capital at the Harvard Management Company in Historical Perspective." Harvard Business School Case 815-047, July 2014.
- September 2001
- Supplement
Millennium Pharmaceuticals, Inc. (B)
By: Stefan H. Thomke and Ashok Nimgade
Supplements the (A) case. View Details
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (B)." Harvard Business School Supplement 602-063, September 2001.
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Pharmaceutical Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- January 2014
- Case
MIT Mystery Hunt: The Answer is Secondary
By: Willy Shih and Karen Robinson
The MIT Mystery Hunt is an annual puzzle-based scavenger hunt at MIT. It is run every year by a different team, and every year is slightly different as teams try new ideas and decide whether to keep or ignore new ideas from previous years. As the Mystery Hunt has... View Details
Keywords: Puzzle-solving; Puzzle Hunt; MIT Mystery Hunt; Innovation and Invention; Collaborative Innovation and Invention; Innovation Leadership; Education Industry; Massachusetts; Cambridge; United States
Shih, Willy, and Karen Robinson. "MIT Mystery Hunt: The Answer is Secondary." Harvard Business School Case 614-050, January 2014.
- 16 Aug 2011
- First Look
First Look: August 16
PublicationsThe World Bank and Democratic Accountability: The Role of Civil Society Authors:Alnoor Ebrahim and Steve Herz Publication:Chap. 3 in Building Global Democracy? Civil Society and Accountable Global Governance, edited by Jan Aart Scholte, View Details
Keywords: Sean Silverthorne
- August 2007 (Revised September 2008)
- Case
Marketing the "$100 Laptop" (A)
By: John A. Quelch and Carin-Isabel Knoop
In 2002, Professor Nicholas Negroponte, a successful venture capitalist, author, and co-founder and chairman emeritus of the Massachusetts Institute of Technology (MIT) Media Lab, announced his intention to build a PC so cheap as to make it possible to provide... View Details
Keywords: Venture Capital; Internet and the Web; Information Technology; Product Development; Technological Innovation; Nonprofit Organizations; Marketing Strategy; Information Infrastructure; Developing Countries and Economies; Manufacturing Industry; Information Technology Industry; Computer Industry; Cambridge
Quelch, John A., and Carin-Isabel Knoop. Marketing the "$100 Laptop" (A). Harvard Business School Case 508-024, August 2007. (Revised September 2008.)
- May 2006 (Revised June 2006)
- Case
Codon Devices
By: Joseph B. Lassiter III and David Kiron
In December 2005, 40-year-old John Danner was about to make his first presentation to the board of directors of Codon Devices, a one-year-old biotechnology start-up based in Cambridge, Massachusetts. After a month as the company's CEO, Danner was prepared to lay out... View Details
Keywords: Strategic Planning; Venture Capital; Intellectual Property; Governing and Advisory Boards; Genetics; Competitive Advantage; Science-Based Business; Business Startups; Growth and Development Strategy; Biotechnology Industry; Cambridge
Lassiter, Joseph B., III, and David Kiron. "Codon Devices." Harvard Business School Case 806-198, May 2006. (Revised June 2006.)
- September 1999 (Revised September 2005)
- Case
Strategic Deal Making at Millennium Pharmaceuticals
A small start-up in 1993, Millennium Pharmaceuticals was a name-brand biotechnology company by the end of 1998, with a market capitalization of $1.4 billion. The Cambridge-based company's growth strategy had relied heavily on building alliances for early-stage drug... View Details
Keywords: Alliances; Negotiation Deal; Growth and Development Strategy; Pharmaceutical Industry; Cambridge
Watkins, Michael D., and Sarah Matthews. "Strategic Deal Making at Millennium Pharmaceuticals." Harvard Business School Case 800-032, September 1999. (Revised September 2005.)
- February 1998 (Revised May 2007)
- Case
Winthrop Park Development
By: William J. Poorvu and Elizabeth McLoughlin
Describes a real estate development project in Cambridge, MA and evaluates the market, financial, and design issues in this $20 million mixed-use property. View Details
Poorvu, William J., and Elizabeth McLoughlin. "Winthrop Park Development." Harvard Business School Case 898-194, February 1998. (Revised May 2007.)
- November 2014
- Case
Napalm: From Soldiers Field to Trang Bang
By: Tom Nicholas and Jonas Peter Akins
Napalm is one of the most destructive weapons ever to be invented. Yet, at its original inception it was nothing more than a technical challenge, and it was never intended to be used in indiscriminate antipersonnel warfare. The pathway of its development by a Harvard... View Details
Keywords: Moral Sensibility; War; Chemicals; Research and Development; Chemical Industry; Viet Nam; Cambridge; United States
Nicholas, Tom, and Jonas Peter Akins. "Napalm: From Soldiers Field to Trang Bang." Harvard Business School Case 815-060, November 2014.